Quantitative analysis of onset timing of interstitial lung disease during treatment with biologics
Not Applicable
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000015358
- Lead Sponsor
- Drug Development and Regulatory Science, Faculty of Pharmacy Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Having diagnostic codes for interstitial lung diseases within 3 days after the treatment initiation. 2. Using anticancer drugs. 3. Under 18-years of age.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method